Jasper Mecklenburg

Berlin, BE, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

Erenumab for Chronic Cluster Headache: A Randomized Clinical Trial.

Erenumab for Chronic Cluster Headache: A Randomized Clinical Trial.

Journal: JAMA network open

Published: June 17, 2025

Development and application of a clinical core data set for deep brain stimulation in Parkinson's disease, dystonia or tremor: from data collection to data exchange and data sharing.

Development and application of a clinical core data set for deep brain stimulation in Parkinson's disease, dystonia or tremor: from data collection to data exchange and data sharing.

Journal: Neurological research and practice

Published: July 26, 2024

Prevalence and characteristics of rapid eye movement sleep behaviour disorder in adults with migraine: a cross-sectional screening study.

Prevalence and characteristics of rapid eye movement sleep behaviour disorder in adults with migraine: a cross-sectional screening study.

Journal: European journal of neurology

Published: April 05, 2024

Alice in Wonderland Syndrome (AIWS): prevalence and characteristics in adults with migraine.

Alice in Wonderland Syndrome (AIWS): prevalence and characteristics in adults with migraine.

Journal: Journal of neurology

Published: March 20, 2024

Near-death experiences are associated with rapid eye movement (REM) sleep intrusions in migraine patients, independent of migraine aura.

Near-death experiences are associated with rapid eye movement (REM) sleep intrusions in migraine patients, independent of migraine aura.

Journal: European journal of neurology

Published: April 28, 2023

Change of CGRP Plasma Concentrations in Migraine after Discontinuation of CGRP-(Receptor) Monoclonal Antibodies.

Change of CGRP Plasma Concentrations in Migraine after Discontinuation of CGRP-(Receptor) Monoclonal Antibodies.

Journal: Pharmaceutics

Published: December 13, 2022

The spectrum of central nervous system involvement in Whipple's disease.

The spectrum of central nervous system involvement in Whipple's disease.

Journal: European journal of neurology

Published: June 19, 2022

Resumption of migraine preventive treatment with CGRP(-receptor) antibodies after a 3-month drug holiday: a real-world experience.

Resumption of migraine preventive treatment with CGRP(-receptor) antibodies after a 3-month drug holiday: a real-world experience.

Journal: The journal of headache and pain

Published: February 23, 2022

Deterioration of headache impact and health-related quality of life in migraine patients after cessation of preventive treatment with CGRP(-receptor) antibodies.

Deterioration of headache impact and health-related quality of life in migraine patients after cessation of preventive treatment with CGRP(-receptor) antibodies.

Journal: The journal of headache and pain

Published: November 08, 2021

Migraine evolution after the cessation of CGRP(-receptor) antibody prophylaxis: a prospective, longitudinal cohort study.

Migraine evolution after the cessation of CGRP(-receptor) antibody prophylaxis: a prospective, longitudinal cohort study.

Journal: Cephalalgia : an international journal of headache

Published: September 28, 2021

Patients' and Health Care Workers' Perception of Migraine Images on the Internet: Cross-sectional Survey Study.

Patients' and Health Care Workers' Perception of Migraine Images on the Internet: Cross-sectional Survey Study.

Journal: Journal of medical Internet research

Published: August 06, 2021

Indirect Comparison of Topiramate and Monoclonal Antibodies Against CGRP or Its Receptor for the Prophylaxis of Episodic Migraine: A Systematic Review with Meta-Analysis.

Indirect Comparison of Topiramate and Monoclonal Antibodies Against CGRP or Its Receptor for the Prophylaxis of Episodic Migraine: A Systematic Review with Meta-Analysis.

Journal: CNS drugs

Published: June 05, 2021

Showing 1-12 of 20

Last Updated: 09/26/2026